Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Abeona Therapeutics (GB:0H7R)
LSE:0H7R
RESEARCH TOOLSreports
Holding GB:0H7R?
Track your performance easily
Abeona Therapeutics (0H7R) Ownership Overview
11.54% Insiders
5.03% Mutual Funds
<0.01% Other Institutional Investors
5.63% ETFs
77.80% Public Companies and
Individual Investors
The ownership structure of Abeona Therapeutics (GB:0H7R) stock is a mix of institutional, retail, and individual investors. Approximately 10.66% of the company’s stock is owned by Institutional Investors, 11.54% is owned by Insiders, and 77.80% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 20, 2024 | Mark Alvino Director | xxxxxxxxxxxxx | $116764 |
| Jun 20, 2024 | Christine Berni Silverstein Director | xxxxxxxxxxxxx | $116453 |
| May 20, 2024 | Leila Alland Director | xxxxxxxxxxxxx | $51700 |
| Apr 29, 2024 | Vishwas Seshadri Ceo,director | xxxxxxxxxxxxx | $32000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $6729299 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,772,121 | Insider | 6.40% | 18,551,034 | |
| 1,935,527 | Institution | 4.47% | 12,952,547 | |
| 1,889,527 | Institution | 4.36% | 12,644,715 | |
| 1,587,099 | Institution | 3.66% | 10,620,867 | |
| 903,887 | Insider | 2.09% | 6,048,812 | |
| 408,584 | Institution | 0.94% | 2,734,244 | |
| 365,217 | Insider | 0.84% | 2,444,032 | |
| 273,289 | Insider | 0.63% | 1,828,850 | |
| 219,327 | Institution | 0.51% | 1,467,736 | |
| 144,365 | Insider | 0.33% | 966,091 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,889,527 | Institution | 4.36% | 12,644,715 | |
| 219,327 | Institution | 0.51% | 1,467,736 | |
| 30,505 | Institution | 0.07% | 204,139 | |
| 23,500 | Institution | 0.05% | 157,262 | |
| 8,850 | Institution | 0.02% | 59,224 | |
| 6,959 | Institution | 0.02% | 46,570 | |
| 374 | Institution | <0.01% | 2,503 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Abeona Therapeutics (GB:0H7R)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 11.54% is held by insiders, and 77.80% is held by retail investors.
What percentage of Abeona Therapeutics (GB:0H7R) stock is held by institutional investors?
According to the latest TipRanks data, approximately <0.01% of Abeona Therapeutics (GB:0H7R) stock is held by institutional investors.
What percentage of Abeona Therapeutics (GB:0H7R) stock is held by retail investors?
According to the latest TipRanks data, approximately 77.80% of Abeona Therapeutics (GB:0H7R) stock is held by retail investors.
Who owns the most shares of Abeona Therapeutics (GB:0H7R)?
Steven A. Cohen owns the most shares of Abeona Therapeutics (GB:0H7R).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.